MENU
APLIF
AS OF
Feb 21 closing price
Price
$0.03
Change
+$0.01 (+50.00%)
Capitalization
2.55M
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
+Compare
APLIF
Stock ticker: OTC
AS OF
Feb 21 closing price
Price
$0.03
Change
+$0.01 (+50.00%)
Capitalization
2.55M

APLIF Appili Therapeutics Inc. Forecast, Technical & Fundamental Analysis

Industry Biotechnology
Ad is loading...
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I. Advisor
published Earnings

APLIF is expected to report earnings to fall ∞% to 0 cents per share on June 27

Appili Therapeutics Inc. APLIF Stock Earnings Reports
Q1'24
Est.
$-0.01
Q4'23
Beat
by $0.01
The last earnings report on February 13 showed earnings per share of 0 cents, beating the estimate of 0 cents. With 13.42K shares outstanding, the current market capitalization sits at 2.55M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1344 Summer Street
Phone
+1 902 442-4655
Employees
9
Web
https://www.appilitherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HEIIX13.44-0.10
-0.74%
Hennessy Equity and Income Institutional
VREQX10.68-0.08
-0.74%
NYLI CBRE Real Estate Class R6
IARRX17.26-0.14
-0.80%
Invesco Real Estate R
CGVFX24.40-0.28
-1.13%
American Funds Global Insight 529-F-1
TIOPX15.45-0.18
-1.15%
Nuveen International Opps Prem

APLIF and Stocks

Correlation & Price change

A.I.dvisor tells us that APLIF and GENFF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APLIF and GENFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLIF
1D Price
Change %
APLIF100%
+3.03%
GENFF - APLIF
25%
Poorly correlated
-33.76%
CTCX - APLIF
21%
Poorly correlated
+0.46%
ARTH - APLIF
12%
Poorly correlated
+9.34%
ARGNF - APLIF
10%
Poorly correlated
N/A
AAVXF - APLIF
9%
Poorly correlated
N/A
More